Inventor · disambiguated record
Christopher Scanlan
Also filed as: SCANLAN CHRISTOPHER · SCANLAN CHRISTOPHER NEIL
0 granted patents·11 pending applications·0 citations·filing 2006–2023
Files withUNITED THERAPEUTICS CORP4IMMAGO BIOSYSTEMS LTD2UNIV OXFORD2CRISPIN MATTHEW DAVID MAX1CRISPIN RAYMOND JOHN1
Top patents by PatentIndex Score
11 records- 0166US2008181913A1Sugar immunogensUNITED THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 0254US2023398212A1Combined therapeutic use of antibodies and immunoglobulin g-degrading enzymesHANSA BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 0351US2006251680A1Mannose immunogens for HIV-1UNITED THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 0451US2008138351A1Liposome treatment of viral infectionsUNITED THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 0549US2010183669A1Mannose immunogens for HIV-1UNIV OXFORD·Filed 2010·Application pending·0 cites
- 0643US2011045021A1Sugar immunogensUNITED THERAPEUTICS CORP·Filed 2010·Application pending·0 cites
- 0741US2011182982A1Liposome treatment of viral infectionsUNIV OXFORD·Filed 2011·Application pending·0 cites
- 0841US2010022620A1Epitope reduction therapyCRISPIN MATTHEW DAVID MAX·Filed 2007·Application pending·0 cites
- 0940US2020345844A1Combined therapeutic use of antibodies and immunoglobulin g-degrading enzymesIMMAGO BIOSYSTEMS LTD·Filed 2020·Application pending·0 cites
- 1030US2015125443A1Combined therapeutic use of antibodies and endoglycosidasesCRISPIN RAYMOND JOHN·Filed 2013·Application pending·0 cites
- 1128US2017274070A1Combined therapeutic use of antibodies and endoglycosidasesIMMAGO BIOSYSTEMS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Scanlan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →